NEURONETICS INC. DL-,01 (NRC.BE)
| Previous close | 2.3900 |
| Open | 2.3300 |
| Bid | 2.3300 x N/A |
| Ask | 2.4800 x N/A |
| Day's range | 2.3100 - 2.3750 |
| 52-week range | 2.2000 - 4.5300 |
| Volume | |
| Avg. volume | 3 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireHumana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
Policy change comes quickly after FDA clearance for NeuroStar TMS use in ages 15 and olderMALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders announced today that Humana has become the first commercial payer to update its policy in response to the Company’s recent clearance from the U.S. Food and Dru
Simply Wall St.Neuronetics, Inc. (NASDAQ:STIM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Shareholders in Neuronetics, Inc. ( NASDAQ:STIM ) had a terrible week, as shares crashed 28% to US$2.55 in the week...
Insider MonkeyNeuronetics, Inc. (NASDAQ:STIM) Q1 2024 Earnings Call Transcript
Neuronetics, Inc. (NASDAQ:STIM) Q1 2024 Earnings Call Transcript May 7, 2024 Neuronetics, Inc. beats earnings expectations. Reported EPS is $-0.26713, expectations were $-0.33. STIM isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. Welcome to the […]
